Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Cancer Immunol Res. 2015 Mar;3(3):288–295. doi: 10.1158/2326-6066.CIR-14-0207

Figure 2.

Figure 2

Immunohistochemical analysis of tumor cell-surface expression of PD-L1 from representative samples (20x). Panel A shows an NRAS-mutant melanoma sample with strongly positive expression (~50% of cells); Panel B shows a WT melanoma with <1% of cells with PDL1 expression. Panel C shows the distribution of PD-L1 staining by genotype. Panel D shows number of samples evaluated by genotype and whether they were positive for PD-L1 expression (≥5%) or negative (<5%).